|
|
|
|
| LEADER |
00000cam a2200000 a 4500 |
| 001 |
SCIDIR_ocn956521072 |
| 003 |
OCoLC |
| 005 |
20231120112127.0 |
| 006 |
m o d |
| 007 |
cr |n||||||||| |
| 008 |
160812s2016 enk o 001 0 eng d |
| 040 |
|
|
|a IDEBK
|b eng
|e pn
|c IDEBK
|d N$T
|d EBLCP
|d OPELS
|d N$T
|d OCLCF
|d OCLCQ
|d QCL
|d OCLCQ
|d MERUC
|d COO
|d OCLCO
|d IUL
|d OCLCO
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCQ
|d MERER
|d OCLCO
|d UPM
|d OCLCO
|d OCLCQ
|d OCLCO
|d YDX
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCQ
|d U3W
|d D6H
|d OCLCO
|d U3G
|d OCLCO
|d CHVBK
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCA
|d LQU
|d OCLCQ
|d UKMGB
|d S2H
|d OCLCO
|d OCLCQ
|d OCLCO
|
| 015 |
|
|
|a GBB6B7892
|2 bnb
|
| 016 |
7 |
|
|a 017986412
|2 Uk
|
| 019 |
|
|
|a 959536675
|a 1015816183
|a 1105193799
|a 1105562417
|a 1151762903
|
| 020 |
|
|
|a 012802609X
|q (electronic bk.)
|
| 020 |
|
|
|a 9780128026090
|q (electronic bk.)
|
| 020 |
|
|
|z 9780128023891
|
| 020 |
|
|
|z 0128023899
|
| 035 |
|
|
|a (OCoLC)956521072
|z (OCoLC)959536675
|z (OCoLC)1015816183
|z (OCoLC)1105193799
|z (OCoLC)1105562417
|z (OCoLC)1151762903
|
| 050 |
|
4 |
|a QH599
|
| 060 |
|
4 |
|a 2016 J-242
|
| 060 |
|
4 |
|a QU 56
|
| 072 |
|
7 |
|a SCI
|x 007000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 572.8/7
|2 23
|
| 245 |
0 |
0 |
|a Chromatin signaling and diseases /
|c edited by Olivier Binda, Martin Ernesto Fernandez-Zapico.
|
| 260 |
|
|
|a London, UK :
|b Academic Press,
|c 2016.
|
| 300 |
|
|
|a 1 online resource (468 pages)
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Translational epigenetics series
|
| 500 |
|
|
|a Includes index.
|
| 588 |
0 |
|
|a Print version record.
|
| 505 |
0 |
|
|a <P>Section I: Histone Mark Writers 1. Histone acetyltransferases, key writers of the epigenetic language Xiang-Jiao Yang</p> <p>2. Impacts of histone lysine methylation on chromatin Sylvain Lanouette, John Haddad, Pamela Zhang and Jean-Fran�cois Couture</p> <p>3. The Role of Histone Mark Writers in Chromatin Signaling: Protein Arginine Methyltransferases Nasim Haghandish and Jocelyn C�ot�e</p> <p>4. Histone Kinases and Phosphatases Nikolaus A. Watson, Jonathan M.G. Higgins</p> <p>Section II: Histone Mark Readers 5. The Bromodomain as Acetyl-Lysine Readers Steven G. Smith, and Ming-Ming Zhou</p> <p>6. Chromo domain proteins Joel C. Eissenberg</p> <p>7. The role of PHD fingers in chromatin signaling: mechanisms and functional consequences of the recognition of histone and non-histone targets Emma A. Morrison and Catherine A. Musselman</p> <p>8. Tudor domains as methyl-lysine and methyl-arginine readers Maria Victoria Botuyan and Georges Mer</p> <p>Section III: Histone Mark Erasers 9. Histone deacetylase, the erasers of the code Mar�ia Julia Lamberti, Emanuel Renzo Vera, Natalia Rumie Vittar Bel�en, G�uenter Schneider</p> <p>10. Lysine Demethylases: Structure, Function and Disfunction Mar�ia Alejandra Garc�ia, Raquel Fueyo, and Marian A. Mart�inez-Balb�as</p> <p>Section IV: Chromatin Signaling 11. Variation, modification and reorganization of broken chromatin Timothy C. Humphrey, Jessica A. Downs, and Anna L. Chambers</p> <p>12. Cross-talk between histone modifications integrates various signaling inputs to fine tune transcriptional output Sankari Nagarajan and Steven A. Johnsen</p> <p>13. Signaling and Chromatin Networks in Cancer Biology Elisabeth Hessmann, Raul Urrutia, and Alexander Koenig</p> <p>Section V: Chromatin Dynamics in Normal and Disease Conditions 14. Crosstalk between DNA methylation and Chromatin Structure Mar�ia Roqu�e and Laura Vargas-Roig 15. Epigenetic regulation of endoplasmic reticulum stress Kim Barroso and Eric Chevet</p> <p>16. Chromatin Signaling in Aging and Cellular Senescense Florence Couteau and Fr�ed�erick A. Mallette</p> <p>17.Chromatin Dynamics and Epigenetics of Stem Cells and Stem-Like Cancer Cells Alexandre Gaspar-Maia and Ana Sevilla</p> <p>18. Altered Chromatin Signaling in Cancer Andrew Liss</p> <p>19. Impact of Chromatin Changes in Pathogenesis of Infectious Disease: A Pathogen View Andrea Ropolo and Maria Carolina Touz</p> <p>20. Chromatin Remodeling and Epigenetic Reprogramming In Chronic Disease and Cancer in the Liver and Pancreas Maite G. Fernandez -- Barrena and Christopher L. Pin</p> <p>21. Pharmacological and Therapeutic Targeting of Epigenetic Regulators Raul Urrutia and Gwen A. Lomberk</p> <p>22. Use of Chromatin Changes as Biomarkers Ryan A. Hlady and Keith D. Robertson</p> <p>23. Regulation of Host Chromatin by Bacterial Metabolites Sridhar Mani </p>
|
| 650 |
|
0 |
|a Chromatin.
|
| 650 |
|
2 |
|a Chromatin
|0 (DNLM)D002843
|
| 650 |
|
6 |
|a Chromatine.
|0 (CaQQLa)201-0062726
|
| 650 |
|
7 |
|a SCIENCE
|x Life Sciences
|x Biochemistry.
|2 bisacsh
|
| 650 |
|
7 |
|a Chromatin
|2 fast
|0 (OCoLC)fst00859922
|
| 700 |
1 |
|
|a Binda, Olivier.
|
| 700 |
1 |
|
|a Fernandez-Zapico, Martin Ernesto.
|
| 776 |
0 |
8 |
|i Print version:
|t Chromatin signaling and diseases.
|d London, UK : Academic Press, 2016
|z 9780128023891
|z 0128023899
|w (OCoLC)938383109
|
| 830 |
|
0 |
|a Translational epigenetics series.
|
| 856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780128023891
|z Texto completo
|
